Halaven and Trigger finger - a phase IV clinical study of FDA data

Summary:

Trigger finger is reported as a side effect among people who take Halaven (eribulin mesylate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Femara, and have Breast cancer.

The phase IV clinical study analyzes which people have Trigger finger when taking Halaven. It is created by eHealthMe based on reports of 3,873 people who have side effects when taking Halaven from the FDA, and is updated regularly.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.

What is Trigger finger?

Trigger finger is found to be associated with 542 drugs and 596 conditions by eHealthMe. Check the latest studies of Trigger finger.

On Jul, 26, 2026

3,873 people reported to have side effects when taking Halaven.
Among them, 11 people (0.28%) have Trigger finger.

Among these 11 people:

How long have people been on Halaven when they have Trigger finger? *

What is the gender of people who have Trigger finger when taking Halaven? *

female: 100 %
male: 0.0 %

What is the age of people who have Trigger finger when taking Halaven? *

What are other drugs people take besides Halaven? *

What are other side effects people have besides Trigger finger? *

Neuropathy Peripheral (surface nerve damage): 9 people, 81.82%
Weight Increased: 2 people, 18.18%
Weakness: 2 people, 18.18%
Blood Glucose Increased: 2 people, 18.18%
Blood Potassium Decreased: 2 people, 18.18%
Blood Sodium Increased: 2 people, 18.18%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 2 people, 18.18%
Breast Lump (localized swelling that feels different from the surrounding breast tissue): 2 people, 18.18%
Creatinine Renal Clearance Decreased: 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%

What are the existing conditions these people have? *

Breast Cancer: 11 people, 100.00%
Neuralgia (pain in one or more nerves): 9 people, 81.82%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 81.82%
Cryoglobulinaemia (blood contains large amounts of cryoglobulins - proteins): 9 people, 81.82%
Pain: 2 people, 18.18%
Malignant Neoplasm Progression (cancer tumour came back): 1 person, 9.09%
Breast Cancer Metastatic: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Halaven and have Trigger finger?

- Check whether Trigger finger is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Halaven:

Halaven (3,881 reports)

Trigger finger treatments and more:

Trigger finger (5,307 reports)

Browse all side effects of Halaven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Trigger finger:

Trigger finger (542 drugs)

Browse all the conditions that are associated with Trigger finger:

Trigger finger (596 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eribulin mesylate (the active ingredients of Halaven) and Halaven (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.